Shares of SI-BONE, Inc. (SIBN) surged 5% in Monday's pre-market trading session, as investors eagerly await the company's second-quarter earnings report scheduled for release after the market close. The medical device company, known for its minimally invasive surgical devices for the sacroiliac joint, has captured investor attention ahead of its financial disclosure.

Wall Street analysts expect SI-BONE to report a loss of $0.18 per share for the quarter. The pre-earnings rally suggests that investors may be optimistic about the company's performance, possibly anticipating results that could beat these expectations. The surge in stock price indicates that market participants are positioning themselves ahead of the announcement, betting on potentially positive surprises in the earnings report.

SI-BONE's stock movement highlights the impact of earnings seasons on investor sentiment. As a player in the growing market for sacroiliac joint treatments, the company's financial results could provide insights into both its individual performance and broader trends in the medical device industry. Investors will be closely watching key metrics such as revenue growth, market expansion, and progress on the path to profitability when the company releases its results later today.